Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02792114
Title T-Cell Therapy for Advanced Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Rimiducid

Mesothelin CAR-T cells

Cyclophosphamide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.